FITC Anti-Human CD44 Antibody[Hermes-1]

The FITC Anti-Human CD44 Antibody [HERMES-1] is a highly specific and reliable tool designed for the detection and analysis of CD44 expression in human samples. This antibody is conjugated with fluorescein isothiocyanate (FITC), a widely used fluorochrome known for its exceptional brightness and stability. With its exceptional specificity and sensitivity, this antibody enables accurate identification and quantification of CD44-positive cells in various research applications.

CD44 is a transmembrane glycoprotein that plays a crucial role in cell adhesion, migration, and signaling. It is involved in numerous physiological and pathological processes, including embryogenesis, inflammation, and cancer metastasis. The HERMES-1 antibody specifically recognizes the standard isoform of CD44, which is widely expressed on the surface of various cell types, including lymphocytes, monocytes, and epithelial cells.

The FITC Anti-Human CD44 Antibody [HERMES-1] offers several advantages over other CD44 antibodies available in the market. Its exceptional specificity ensures minimal cross-reactivity with other antigens, resulting in highly reliable and accurate results. The FITC conjugation provides excellent fluorescence intensity, allowing for easy detection and visualization of CD44-positive cells using flow cytometry or fluorescence microscopy.

This antibody has been extensively validated in various experimental settings, including immunohistochemistry, flow cytometry, and Western blotting. It has demonstrated consistent and reproducible results, making it an ideal choice for researchers in the fields of immunology, oncology, and stem cell research.

The FITC Anti-Human CD44 Antibody [HERMES-1] is supplied as a ready-to-use solution, eliminating the need for time-consuming antibody conjugation procedures. It is provided in a convenient 1 mL vial, ensuring sufficient volume for multiple experiments. The antibody is stored at 4°C, ensuring long-term stability and preserving its functionality.

In summary, the FITC Anti-Human CD44 Antibody [HERMES-1] is a highly specific, sensitive, and reliable tool for the detection and analysis of CD44 expression in human samples. Its exceptional performance and ease of use make it an invaluable asset for researchers aiming to unravel the complex roles of CD44 in various biological processes.